Latest PLoS Pathogens Stories
Mycobacterium tuberculosis is a major cause of death worldwide, and a formidable foe.
An international team of scientists showed that by swapping a single amino acid they could change the sugar to which the human BK polyomavirus will bind on the surface of cells.
Researchers at the University of Georgia have discovered that a combination of two commonly prescribed drugs used to treat high cholesterol and osteoporosis may serve as the foundation of a new treatment for toxoplasmosis, a parasitic infection caused by the protozoan Toxoplasma gondii.
Creating an environment that nurtures the trillions of beneficial microbes in our gut and, at the same time, protects us against invasion by food-borne pathogens is a challenge.
The immune response to the bacterium that causes tuberculosis (TB) varies between patients of different ethnic origin, raising important implications for the development of tests to diagnose and monitor treatment for the disease.
A new report suggests that the concentration of one human cytokine, interleukin 7 (IL-7), in the semen of HIV-1-infected men may be a key determinant of the efficiency of HIV-1 transmission to an uninfected female partner.
A genetically reprogrammed Herpes simplex virus (HSV) can cure metastatic diffusion of human cancer cells in the abdomen of laboratory mice.
One third of the world is infected with the bacterium that causes tuberculosis (TB), a disease that is increasingly difficult to treat because of wide spread resistance to available drugs.
A new study shows that a microbicide gel is highly effective in block infection by the AIDS virus in a non-human primate model.
A new study demonstrates for the first time how the Toxoplasma gondii parasite enters the brain to influence its host's behavior.